Brian Bloomquist, PhD
Brian Bloomquist, PhD is the Senior Director of Global External R&D with Eli Lilly and Company. Brian has been at Lilly since April 2006 where his role within the Global External R&D group is to lead the evaluation of external partnering opportunities in diabetes and endocrine disease for technical merit and portfolio fit. Prior to coming to Lilly, he spent 11 years in the Metabolic Disorders group at Bayer Pharmaceuticals where his laboratory was engaged in obesity drug discovery and he held multiple leadership positions in the management of the Obesity Research portfolio. Brian completed his post-doctoral studies at The Johns Hopkins University School of Medicine where he studied dopaminergic signaling following his graduate studies at Purdue University where he investigated Drosophila photoreceptor signal transduction and his thesis was awarded the first A.H. Ismail Interdisciplinary Dissertation Award. Dr. Bloomquist is an inventor on a number of patents and is the author of multiple peer-reviewed publications, including an article highlighted on the cover of the journal Cell.